top of page

Search Results

Results found for "Inversago Pharma"

  • When January Looks Different by March: Orthosteric vs. Allosteric Insights from Our Latest AMA

    Terry’s Pharmacology Corner is built around that reality. continuous learning environment — supporting scientific reasoning as programs mature, rather than treating pharmacology Why Terry’s Pharmacology Corner Mechanistic understanding evolves. Terry’s Pharmacology Corner provides a structured environment for that evolution: Weekly advanced pharmacology Forty years of pharmacological expertise — organized into a year-round learning framework for serious

  • Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early

    risks for safety profiles Proactive detection methodology arms discovery teams with actionable insight Pharmacokinetic Pharmacokinetic approaches are adapted, sometimes employing exotic carriers or solvents to maximize exposure Purpose-driven exposure strategies enhance detection Unique pharmacokinetics may be required for robust design cycles Computational prediction complements biological screening Why Terry’s Corner Terry’s Pharmacology As GPCR science and pharmacological innovation accelerate, timely guidance from foundational to advanced

  • Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls

    Orthosteric binding experiments remain a cornerstone of pharmacology, but they demand rigor. Complex Two-Stage Biology Behind Orthosteric Binding GPCR pharmacology rarely follows the neat Langmuir Why Terry’s Corner Weekly pharmacology sessions with Dr. Built for pharmacologists strengthening fundamentals, program teams navigating bottlenecks, and leaders

  • When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue

    They unlocked pharmacologically relevant insights that were previously inaccessible.

  • Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids

    Despite its therapeutic potential, CB2 pharmacology remains difficult to interrogate with confidence. For researchers working in cannabinoid pharmacology, inflammation, or GPCR-mediated analgesia, these

  • How Collaboration Drives GPCR Discoveries

    what they weren’t built for, JB’s group engineered fluorescent ligands based on known GLP-1 and GIP pharmacology They’re team problems — the kind that require chemistry, physiology, pharmacology, structural biology

  • High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands

    where receptor trafficking, spatial dynamics, and context-dependent signaling significantly influence pharmacology for Modern Screening Needs Radioligand binding assays have historically been the standard for GPCR pharmacology , preserving receptor conformation, trafficking, and native membrane context—key variables for GPCR pharmacology For teams working in GPCR pharmacology or cannabinoid research, these tools accelerate hit validation

  • From Farm Fields to GPCR Discovery, GLP-1 and GIP

    agricultural settings inspired him to train in veterinary medicine, where he was introduced to physiology and pharmacology

  • How Schild Analysis Protects Your Conclusions in GPCR Research

    Upcoming events:  GPCR-TDD Europe; Pharmacology 2026. Researchers navigating complex datasets, balancing innovation with assay rigor, or working across chemistry–pharmacology–physiology GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

  • How GPCR Collaboration Built an Innovation Engine

    What emerged wasn’t just another pharmacology group — it became a collaborative engine for GPCR discovery Turning Silos into Systems The early 2000s were not kind to exploratory pharmacology. But at Monash Institute of Pharmaceutical Sciences, a different idea took root: what if collaboration Why This Matters GPCR research demands integration — pharmacology, structural biology, signaling pathways

  • Molecular creativity in drug discovery

    Welcome GPCR Fans, Most pharmacologists are trained to chase targets. Upcoming events:  Global GPCR summits and pharmacology forums shaping 2026 priorities. Innovation : Her lab model at Monash is shaping the next generation of GPCR scientists. 👉 Dive into spatial pharmacology GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

  • Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery

    the chemical matter  interacting with that target lacks the right properties to produce meaningful pharmacology In this lesson, you’ll gain: A strategic view of how chemical scaffolds shape pharmacologic outcomes It was early structure-based pharmacology. Dr. They are mainstream pharmacology. Advances in formulation and delivery have overcome earlier pharmacokinetic limitations.

  • GPCR Collaboration: From Models to Medicine

    GPCRs demanded something different: the integration of modeling, medicinal chemistry, and pharmacology Pharmacologists know they aren’t being oversold. A pharmacologist who understands docking, or a modeler who knows assay constraints, will collaborate

  • Innovative Data-Driven Solutions: The pHSense Revolution

    This innovation emerged from years of foundational work in photophysics and GPCR pharmacology.

  • Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024

    Allosteric GPCR Binding Sites and Their Ligandability Potential Today, we started the Principles of Pharmacology Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and GPCRs-Targeted Drug Discovery Summit Europe July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group Postdoctoral

  • How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs

    yes—but also a deep partnership with GPCR legend Terry Kenakin to bridge industry credibility with pharmacological That opened the door to something rare in functional pharmacology: plate-based GPCR internalization tracking internalization of endogenous GLP-1 receptors in rat beta cells—with no overexpression, no imaging, and no pharmacological

  • Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research

    FRET-based technologies by providing high-performance fluorescent ligands designed specifically for pharmacological

  • Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies

    Biomed Pharmacother. 2018 Feb;98:222-232. doi: 10.1016/j.biopha.2017.12.056 Azam S, Haque ME, Jakaria

  • How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights

    This Week’s GPCR Intelligence: From Set-Point Pharmacology to No-Wash Internalization Assays This week structure-encoded location-biased signaling, GPCR signaling in metabolism, and future directions in biased ligand pharmacology GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

  • How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)

    Career opportunities:  Snapshot of roles spanning PhD entry points to senior translational pharmacology—Protein Expression, Drug Discovery Scientist, and Staff Scientist in Molecular Pharmacology—curated with notes GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

  • Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right

    Nordisk looks to next generation of obesity, diabetes drugs with $550M Replicate research deal; Rhythm Pharmaceuticals Associate; Senior Scientist, Data Science—curated roles aligned to GPCR discovery and translational pharmacology GPCR scientists, translational pharmacologists, biotech discovery teams, platform company leaders, and Access this week’s full Premium Edition here ➤ What our members say 🗣️ "The best pharmacology teacher Also super-valuable for those of us learning how to teach pharmacology." — DrGPCR University Attendee

  • Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining

    . -            Biased signaling detection Biased pharmacophores may be used in conjunction with fluorescent Flow Cytometry validation performed in the Oncological Pharmacology Laboratory of the University of Turin

  • From Snapshots to Predictions: Why Mechanism of Action Matters

    By the end, you’ll know how to use pharmacological models to separate lookalikes, explain puzzling outcomes When Two Mechanisms Look the Same Some of the most difficult calls in pharmacology happen when two different Built for discovery-phase teams, pharmacologists refining fundamentals, scientists challenging legacy

  • How a Failed Med School Dream Sparked a GPCR Biotech Revolution

    His work spans deep academic research, startup life, and the application of machine learning and pharmacology Superluminal Medicines: AI/ML Meets GPCR Pharmacology As Ajay continued to explore how GPCR signaling Despite decades of progress in structural biology and pharmacology, predicting how  a GPCR will respond

  • How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision

    for proteins: Tracking the motions of cell receptors; A Better Way to Treat Obesity; Unlocking the pharmacological climbing the spotlight; new tools tracking receptor motion; obesity drug strategies shifting; antibody pharmacology Ajay Yekkirala shares the journey from academic pharmacologist to biotech entrepreneur—bridging curiosity GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

  • Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells

    This is why fluorescent tags, both attached to the protein or to pharmacophores, are so interesting. In the case of fluorescent ligands , where a fluorescent tag is attached to a pharmacophore , the receptor studies, it facilitates the structural context necessary to map receptor localization in defined states (pharmacological Br J Pharmacol. 2023 Dec 12. doi: 10.1111/bph.16297. 

  • Allosteric Binding Demystified: Smarter GPCR Drug Discovery

    Terry's Corner - The Truth About Allosteric Displacement Allosteric binding isn’t just a twist in the pharmacology GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

  • The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think

    Understand the synergistic mechanisms driving the escalating opioid crisis and the crucial role of GPCR pharmacology Problem Solved:  Gain a deeper understanding of the pharmacological underpinnings of opioid overdose, Listen now to understand how two mechanisms intersect—and why pharmacologists are critical in addressing GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need Access this week’s full Premium Edition here ➤ What our members say 🗣️ “The best pharmacology teacher

  • Fluorescence Polarization in GPCR Research

    They provide rapid and scalable assessment of pharmacological parameters.

  • Advantages of Fluorescent Probes in GPCR Assays

    Fluorescent Probes in GPCR assays over other methods Fluorescent ligands are made by choosing an adequate pharmacophore They can also further pharmacological and structural studies, as they can be used to determine receptor Our portfolio also includes all kinds of dyes, such as pharmacophores conjugated to near-infrared fluorophores Biomed Pharmacother. 2022 Sep;153:113408. doi: 10.1016/j.biopha.2022.113408. Br J Pharmacol. 2020 Mar;177(5):978-991. doi: 10.1111/bph.14953.

bottom of page